Cystic Fibrosis 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Cystic Fibrosis trials.

Effective solutions for advancing Cystic Fibrosis research

Thanks to advancements in treatment, people with cystic fibrosis (CF) live longer than ever before, but work remains to develop safe and effective disease-modifying therapies. Signant Health can support the drug development process by applying our Signant SmartSignals clinical research solutions as well as scientific expertise to help researchers improve trial outcomes.

DMD-1

Why Signant Health

  • Capture Better ePRO Data & Keep Patients Engaged
  • Gain Additional Expert Guidance
  • Conduct Study Activities Remotely
  • Simplify Medication Management
  • Minimize Participation Burdens
  • Digitalize Your Research Processes
  • Capture Better ePRO Data & Keep Patients Engaged

    Capture Better ePRO Data & Keep Patients Engaged

    In one platform, Signant's eCOA solution provides clinicians and patients with tools to improve the assessment experience. Electronic administration of PROs such as CFQ/CFQ-R makes it easier to complete them at home or site, and produces more accurate data. Built-in patient engagement features also help keep participants on track and adherent.

  • Gain Additional Expert Guidance

    Gain Additional Expert Guidance

    With decades of clinical science experience, our CF and rare disease research leaders are prepared to serve as an extension of your study team. Rely on our in-house experts to help optimize protocols, implement clinically-appropriate instruments, and oversee data quality from launch through regulatory submission.
     

  • Conduct Study Activities Remotely

    Conduct Study Activities Remotely

    Reach the participants you need to meet enrollment goals by offering solutions that facilitate remote study activities. From RTSM to eConsent, eCOA, and Telemedicine, Signant's comprehensive range of solutions and global project teams will help you conduct trial activities anywhere and any way.
     

  • Simplify Medication Management

    Simplify Medication Management

    Take control of inventory management for numerous medications and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Our agile design process will help you launch quickly and manage mid-study changes with ease. Plus, a dedicated team experienced in CF protocols will support your trial operations no matter how or where you conduct your trials.

  • Minimize Participation Burdens

    Minimize Participation Burdens

    Make study participation more convenient for patients and sites. With eConsent, patients can take their time reviewing study requirements at home before making the effort to visit the clinic. Once enrolled, your team can leverage our secure, compliant Telemedicine platform to connect with patients between visits or for appointments not requiring site-based assessments.
     

  • Digitalize Your Research Processes

    Digitalize Your Research Processes

    Each solution and service within our Signant SmartSignals evidence generation platform can be applied to a study independently. However, when combined, they create an intuitive and powerful digital ecosystem for creating and managing complex global studies. Plus, every study is supported by a dedicated team of clinical science and operations experts.
     

Comprehensive Cystic Fibrosis experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Cystic Fibrosis trial resources
SOLUTION BROCHURE

Cystic Fibrosis Trial Solutions Overview



GET INSIGHTS
VIDEO

Cystic Fibrosis Trial Solutions




WATCH [2 MIN]
CASE STUDY

Signant Steps in to Help Sponsor's Rare Pediatric Disease Trial

 
 
READ CASE STUDY

Ready to learn more?

Discover how Signant can support your current or upcoming cystic fibrosis trials.